Supernus [SUPN] vs Elanco Animal Health [ELAN] Detailed Stock Comparison
Supernus
NASDAQ
Loading...
Elanco Animal Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Supernus wins in 8 metrics, Elanco Animal Health wins in 11 metrics, with 0 ties. Elanco Animal Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Supernus | Elanco Animal Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 39.03 | 19.88 | Elanco Animal Health |
| Price-to-Book Ratio | 2.37 | 1.28 | Elanco Animal Health |
| Debt-to-Equity Ratio | 2.99 | 62.13 | Supernus |
| PEG Ratio | 3.51 | -0.17 | Elanco Animal Health |
| EV/EBITDA | 15.32 | 14.68 | Elanco Animal Health |
| Profit Margin (TTM) | 9.70% | 9.68% | Supernus |
| Operating Margin (TTM) | 6.73% | 6.85% | Elanco Animal Health |
| EBITDA Margin (TTM) | 6.73% | 6.85% | Elanco Animal Health |
| Return on Equity | 6.38% | 6.83% | Elanco Animal Health |
| Return on Assets (TTM) | 2.39% | 0.98% | Supernus |
| Free Cash Flow (TTM) | $171.23M | $380.00M | Elanco Animal Health |
| 1-Year Return | 28.34% | 22.92% | Supernus |
| Price-to-Sales Ratio (TTM) | 3.78 | 1.94 | Elanco Animal Health |
| Enterprise Value | $2.03B | $12.36B | Elanco Animal Health |
| EV/Revenue Ratio | 3.05 | 2.76 | Elanco Animal Health |
| Gross Profit Margin (TTM) | 89.83% | 57.45% | Supernus |
| Revenue per Share (TTM) | $12 | $9 | Supernus |
| Earnings per Share (Diluted) | $1.15 | $0.88 | Supernus |
| Beta (Stock Volatility) | 0.74 | 1.66 | Supernus |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Supernus vs Elanco Animal Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Supernus | 3.60% | 5.13% | 37.37% | 40.07% | 37.33% | 23.20% |
| Elanco Animal Health | 2.40% | -0.28% | 19.96% | 41.36% | 61.21% | 48.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Supernus | 28.34% | 32.62% | 102.80% | 152.13% | 651.76% | 651.76% |
| Elanco Animal Health | 22.92% | 16.45% | -38.52% | -47.48% | -47.48% | -47.48% |
Performance & Financial Health Analysis: Supernus vs Elanco Animal Health
| Metric | SUPN | ELAN |
|---|---|---|
| Market Information | ||
| Market Cap | $2.52B | $8.69B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 854,070 | 6,364,160 |
| 90 Day Avg. Volume | 969,440 | 5,756,047 |
| Last Close | $44.88 | $17.91 |
| 52 Week Range | $29.16 - $45.01 | $8.02 - $18.09 |
| % from 52W High | -0.29% | -1.00% |
| All-Time High | $61.25 (Jun 25, 2018) | $37.61 (Sep 24, 2018) |
| % from All-Time High | -26.73% | -52.38% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.05% |
| Quarterly Earnings Growth | 0.13% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.10% |
| Operating Margin (TTM) | 0.07% | 0.07% |
| Return on Equity (TTM) | 0.06% | 0.07% |
| Debt to Equity (MRQ) | 2.99 | 62.13 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $18.96 | $13.64 |
| Cash per Share (MRQ) | $9.32 | $1.09 |
| Operating Cash Flow (TTM) | $187.06M | $572.00M |
| Levered Free Cash Flow (TTM) | $150.12M | $1.21B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Supernus vs Elanco Animal Health
| Metric | SUPN | ELAN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 39.03 | 19.88 |
| Forward P/E | 23.75 | 18.61 |
| PEG Ratio | 3.51 | -0.17 |
| Price to Sales (TTM) | 3.78 | 1.94 |
| Price to Book (MRQ) | 2.37 | 1.28 |
| Market Capitalization | ||
| Market Capitalization | $2.52B | $8.69B |
| Enterprise Value | $2.03B | $12.36B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.05 | 2.76 |
| Enterprise to EBITDA | 15.32 | 14.68 |
| Risk & Other Metrics | ||
| Beta | 0.74 | 1.66 |
| Book Value per Share (MRQ) | $18.96 | $13.64 |
Financial Statements Comparison: Supernus vs Elanco Animal Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SUPN | ELAN |
|---|---|---|
| Revenue/Sales | $149.82M | $1.19B |
| Cost of Goods Sold | $15.76M | $509.00M |
| Gross Profit | $134.06M | $684.00M |
| Research & Development | $26.93M | $94.00M |
| Operating Income (EBIT) | $-2.60M | $121.00M |
| EBITDA | $25.45M | $270.00M |
| Pre-Tax Income | $-5.83M | $60.00M |
| Income Tax | $6.00M | $-7.00M |
| Net Income (Profit) | $-11.83M | $67.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SUPN | ELAN |
|---|---|---|
| Cash & Equivalents | $115.85M | $487.00M |
| Total Current Assets | $687.58M | $3.44B |
| Total Current Liabilities | $281.77M | $1.27B |
| Long-Term Debt | $26.37M | $4.35B |
| Total Shareholders Equity | $1.03B | $6.35B |
| Retained Earnings | $544.60M | $-1.88B |
| Property, Plant & Equipment | $0 | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SUPN | ELAN |
|---|---|---|
| Operating Cash Flow | $22.33M | $-4.00M |
| Capital Expenditures | $-327,000 | $-65.00M |
| Free Cash Flow | $30.27M | $-69.00M |
| Debt Repayment | N/A | $-178.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SUPN | ELAN |
|---|---|---|
| Shares Short | 5.08M | 23.96M |
| Short Ratio | 6.80 | 5.44 |
| Short % of Float | 0.13% | 0.07% |
| Average Daily Volume (10 Day) | 854,070 | 6,364,160 |
| Average Daily Volume (90 Day) | 969,440 | 5,756,047 |
| Shares Outstanding | 55.74M | 494.45M |
| Float Shares | 48.90M | 492.94M |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 1.09% | 1.10% |
Dividend Analysis & Yield Comparison: Supernus vs Elanco Animal Health
| Metric | SUPN | ELAN |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |